(Q35557271)

8 August 2017

1 reference

title

BTLA: a new inhibitory receptor with a B7-like ligand (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

20 March 2024

2

Mary Collins

1 reference

8 August 2017

Beatriz M. Carreno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552835

20 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14552835

20 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1471490603002679?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

https://api.elsevier.com/content/article/PII:S1471490603002679?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

20 March 2024

1 reference

8 August 2017

volume

24

1 reference

8 August 2017

issue

10

1 reference

8 August 2017

page(s)

524-527

1 reference

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

20 March 2024

The B7-CD28 superfamily

2

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

20 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

20 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

What's the difference between CD80 and CD86?

20 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

20 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

B7S1, a novel B7 family member that negatively regulates T cell activation

20 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

20 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

20 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

PD-1: an inhibitory immunoreceptor involved in peripheral tolerance

20 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation

20 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cells

20 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

Immune inhibitory receptors

20 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

The dual-function CD150 receptor subfamily: the viral attraction

20 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

20 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss

20 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production

20 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

20 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

20 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

Thymocyte development is normal in CTLA-4-deficient mice

20 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

20 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

20 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.IT.2003.08.005

20 March 2024

Identifiers

1 reference

8 August 2017

1 reference